株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

タンパク質発現の世界市場予測 2022年:原核生物・哺乳類細胞・昆虫細胞・イースト・無細胞・藻類由来

Protein Expression Market by Type (E. Coli, Mammalian, Yeast, Pichia, Insect, Baculovirus, Cell-free), Products (Competent Cells, Reagents, Instruments, Services), Application (Therapeutic, Research, Industrial) & End User - Global Forecast to 2022

発行 MarketsandMarkets 商品コード 300765
出版日 ページ情報 英文 176 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.21円で換算しております。
Back to Top
タンパク質発現の世界市場予測 2022年:原核生物・哺乳類細胞・昆虫細胞・イースト・無細胞・藻類由来 Protein Expression Market by Type (E. Coli, Mammalian, Yeast, Pichia, Insect, Baculovirus, Cell-free), Products (Competent Cells, Reagents, Instruments, Services), Application (Therapeutic, Research, Industrial) & End User - Global Forecast to 2022
出版日: 2017年07月04日 ページ情報: 英文 176 Pages
概要

世界のタンパク質発現市場規模は、2017年の16億5,400万米ドルから、2022年までに28億5,050万米ドルへ11.5%のCAGR (年間複合成長率) で拡大すると予測されています。同市場の促進因子は、慢性疾患の有病率の増加、タンパク質発現システムの分野における技術進歩、およびタンパク質ベースの研究に対する資金の増大です。一方、市場統合の拡大およびタンパク質発現試薬・器具の高コストは、同市場の成長を抑制しています。

当レポートでは、タンパク質発現市場について調査分析し、市場概要、産業動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • タンパク質発現:市場概要
  • 地域分析:タンパク質発現市場、エンドユーザー別
  • タンパク質発現市場:システムタイプ別
  • タンパク質発現市場の地域概要

第5章 市場概要

  • イントロダクション
  • 市場ダイナミクス
    • 市場促進因子
    • 市場阻害因子
    • 市場機会
    • 課題

第6章 世界のタンパク質発現市場:システムタイプ別

  • 原核生物発現システム
  • 哺乳類細胞発現システム
  • 昆虫細胞発現システム
  • イースト発現システム
  • 無細胞発現システム
  • 藻類由来発現システム

第7章 世界のタンパク質発現市場:製品・サービス別

  • イントロダクション
  • 試薬
  • 発現ベクター
  • 適格細胞
  • 器具
  • サービス

第8章 世界のタンパク質発現市場:用途別

  • イントロダクション
  • 治療用
  • 工業用
  • 研究用

第9章 世界のタンパク質発現市場:エンドユーザー別

  • イントロダクション
  • 医薬品・バイオテクノロジー企業
  • 大学研究機関
  • CRO
  • その他のエンドユーザー

第10章 世界のタンパク質発現市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア
  • その他

第11章 競合環境

  • イントロダクション
  • 競合リーダーシップマッピング

第12章 企業プロファイル

  • 主要企業
    • THERMO FISHER SCIENTIFIC INC.
    • MERCK KGAA
    • GENSCRIPT BIOTECH CORPORATION
    • AGILENT TECHNOLOGIES, INC.
    • タカラバイオ
    • PROMEGA CORPORATION
    • BIO-RAD LABORATORIES, INC.
    • QIAGEN N.V.
    • LONZA GROUP LTD.
    • NEW ENGLAND BIOLABS INC.
  • 主要イノベーター
    • SENGENICS
    • PROTEOGENIX
    • SYNTHETIC GENOMICS INC.

第13章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: BT 2435

The protein expression market was valued at USD 1,654.0 million in 2017 and is expected to grow at a CAGR of 11.5% to a USD 2,850.5 million market by 2022. Factors driving this market are the increasing prevalence of chronic disorders, technological advancements in the field of protein expression systems, and increasing funding for protein-based research. On the other hand, rising market consolidation and the high cost of protein expression reagents and instruments are restraining the growth of this market.

Mammalian cell expression systems segment is expected to register the highest CAGR during the forecast period

The protein expression market is classified into insect cell expression systems; mammalian cell expression systems; prokaryotic expression systems, yeast expression systems; cell-free expression systems; and algal-based expression systems, on the basis of systems type. The mammalian cell expression system segment is expected to register the highest growth rate during the forecast period. This growth can be attributed to the high adoption of these systems in the protein based reasech and therapeutic protein manufacturing as they have the capacity for post-translational modification and human protein-like molecular structure assembly.

Reagents segment is expected to register the highest CAGR during the forecast period

The protein expression market is classified by products, into competent cells, expression vectors, instruments, reagents, and services. The reagents segment is expected to register highest growth rate during the forecast period. This growth can be attributed to the increase in protein expression research activities and the large-scale production of antibodies and vaccines.

Increasing prevalence of chronic disorders to drive growth of the therapeutic applications segment

Based on application, the global protein expression market is segmented into therapeutic applications, industrial applications, and research applications. The therapeutic application segment is expected to register highest CAGR during the forecast period. The growth in this segment is primarily attributed to increasing incidences of chronic disorders and the rising demand for therapeutic proteins.

The CROs end-user segment is expected to register high growth during the forecast period

The protein expression market is classified on the basis of end users into academic research institutes; contract research organizations (CROs); pharmaceutical and biotechnology companies; and other end users (food processing industry, detergent manufacturers, paper industry, leather industry, breweries, dairy industry, chemical industry, bioplastic industry, and cosmeceutical industry). The CROs segment is expected to register highest growth rate during the forecast period. This growth can be attributed to the increase in outsourcing of pharmaceutical manufacturing/clinical trial processes.

North America is account for the largest regional segment in the market

Geographically, the protein expression systems market is dominated by North America, followed by Europe. The North American region is estimated to account for the largest share in 2017 and this trend is expected to continue during the forecast period. Growth in this market can be attributed to the presence of major key players in the region, technological advancements, growth in the biotechnology and pharmaceutical industries, and rising prevalence of chronic diseases.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type - Tier 1 - 25 %, Tier 2 - 35% and Tier 3 - 40%
  • By Designation - C level - 35%, Director level - 25%, Others - 40%
  • By Region - North America - 43%, Europe - 19%, APAC - 29%, RoW - 9%

Key players operating in the protein expression market include Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), GenScript Biotech Corporation (China), Agilent Technologies Inc. (U.S.), Takara Bio, Inc. (Japan), Promega Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.) , QIAGEN N.V. (The Netherlands) , Lonza Group Ltd.(Switzerland), and New England Biolabs Inc.(U.S.)

Study Coverage:

This report analyses the protein expression market by systems type, systems type, products, applications, end users, and regions. Apart from offering a comprehensive geographic and product analysis and market sizing, the report also provides the competitive landscape that covers the growth strategies adopted by industry players over the last three years. The report also profiles companies with product portfolios, developments, and strategies adopted by key players to maintain and increase their shares in the market. The above-mentioned market research data, market size, and forecast of the future trends will help key market players and new entrants make the necessary decisions to be successful in the market.

Benefits of Buying the Report:

This report will enable both established firms as well as new entrants/smaller firms gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the five strategies mentioned below to strengthen their market shares.

The report provides insights on the following strategies:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the protein expression market. The report analyzes the protein expression market by systems type, product, application and end user
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the protein expression market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various protein expression products across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the protein expression market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
  • 1.4. YEARS CONSIDERED FOR THE STUDY
  • 1.5. CURRENCY
  • 1.6. LIMITATIONS
  • 1.7. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. SECONDARY DATA
  • 2.2. PRIMARY DATA
  • 2.3. MARKET SIZE ESTIMATION
    • 2.3.1. BOTTOM-UP APPROACH
    • 2.3.2. TOP-DOWN APPROACH
  • 2.4. DATA TRIANGULATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. PROTEIN EXPRESSION: MARKET OVERVIEW
  • 4.2. GEOGRAPHIC ANALYSIS: PROTEIN EXPRESSION MARKET, BY END USER (2017)
  • 4.3. PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2017-2022
  • 4.4. GEOGRAPHICAL SNAPSHOT OF THE PROTEIN EXPRESSION MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increasing incidence of chronic diseases
        • 5.2.1.1.1. Growth in the geriatric population
        • 5.2.1.1.2. Increasing demand for protein biologics
      • 5.2.1.2. Growth in life sciences and biopharmaceutical industries
      • 5.2.1.3. Increasing research activities on recombinant-based protein expression
      • 5.2.1.4. Availability of funding for protein-based research
      • 5.2.1.5. Technological advancements in protein expression systems
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High cost of protein expression reagents and instruments
      • 5.2.2.2. Increasing consolidation and high barriers for new entrants
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Emergence of microfluidics
      • 5.2.3.2. Emerging economies offer ample growth potential
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Contamination-a major challenge in protein purification
      • 5.2.4.2. Complexities associated with membrane protein expression and purification

6. GLOBAL PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE

  • 6.1. INTRODUCTION
  • 6.2. PROKARYOTIC EXPRESSION SYSTEMS
    • 6.2.1. ESCHERICHIA COLI SYSTEMS
    • 6.2.2. OTHER PROKARYOTIC EXPRESSION SYSTEMS
  • 6.3. MAMMALIAN CELL EXPRESSION SYSTEMS
    • 6.3.1. CHINESE HAMSTER OVARY SYSTEMS
    • 6.3.2. OTHER MAMMALIAN CELL SYSTEMS
  • 6.4. INSECT CELL EXPRESSION SYSTEMS
    • 6.4.1. BACULOVIRUS SYSTEMS
    • 6.4.2. OTHER INSECT CELL SYSTEMS
  • 6.5. YEAST EXPRESSION SYSTEMS
    • 6.5.1. K. LACTIS SYSTEMS
    • 6.5.2. SACCHAROMYCES SYSTEMS
    • 6.5.3. PICHIA SYSTEMS
    • 6.5.4. OTHER YEAST EXPRESSION SYSTEMS
  • 6.6. CELL-FREE EXPRESSION SYSTEMS
  • 6.7. ALGAL-BASED EXPRESSION SYSTEMS

7. GLOBAL PROTEIN EXPRESSION MARKET, BY PRODUCT AND SERVICE

  • 7.1. INTRODUCTION
  • 7.2. REAGENTS
  • 7.3. EXPRESSION VECTORS
  • 7.4. COMPETENT CELLS
  • 7.5. INSTRUMENTS
  • 7.6. SERVICES

8. GLOBAL PROTEIN EXPRESSION MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. THERAPEUTIC APPLICATIONS
  • 8.3. INDUSTRIAL APPLICATIONS
  • 8.4. RESEARCH APPLICATIONS

9. GLOBAL PROTEIN EXPRESSION MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
  • 9.3. ACADEMIC RESEARCH INSTITUTES
  • 9.4. CONTRACT RESEARCH ORGANIZATIONS
  • 9.5. OTHER END USERS

10. GLOBAL PROTEIN EXPRESSION MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. GERMANY
    • 10.3.2. FRANCE
    • 10.3.3. U.K.
    • 10.3.4. ITALY
    • 10.3.5. SPAIN
    • 10.3.6. REST OF EUROPE (ROE)
  • 10.4. ASIA
    • 10.4.1. CHINA
    • 10.4.2. JAPAN
    • 10.4.3. INDIA
    • 10.4.4. REST OF ASIA (ROA)
  • 10.5. REST OF THE WORLD (ROW)

11. COMPETITIVE LANDSCAPE

  • 11.1. INTRODUCTION
    • 11.1.1. VISIONARY LEADERS
    • 11.1.2. INNOVATORS
    • 11.1.3. DYNAMIC DIFFERENTIATORS
    • 11.1.4. EMERGING COMPANIES
  • 11.2. COMPETITIVE LEADERSHIP MAPPING
    • 11.2.1. STRENGTH OF PRODUCT PORTFOLIO (25 PLAYERS)
    • 11.2.2. BUSINESS STRATEGY EXCELLENCE (25 PLAYERS)
  • 11.3. MARKET SHARE ANALYSIS

Top 25 companies analyzed for this study are - Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson & Company (U.S.), Agilent Technologies, Inc. (U.S.), QIAGEN N.V. (Netherlands), Takara Bio Inc. (Japan), Lonza Group Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), GenScript Biotech Corporation (China), Lucigen Corporation (U.S.), Synthetic Genomics Inc. (U.S.), Promega Corporation (U.S.), New England Biolabs, Inc. (U.S.), Sengenics (Singapore.), ARTES Biotechnology GmbH (Germany), Addgene Inc. (U.S.) , LifeSensors Inc. (U.S.), Accelagen Inc. (U.S.), Geneva Biotech (Switzerland), Viva Biotech (China), Profacgen (U.S.), ProteoGenix (France), Peak Proteins Ltd. (U.K.), Domainex Ltd. (U.K.), and Jena Bioscience GmbH (Germany).

12. COMPANY PROFILES (OVERVIEW, PRODUCTS AND SERVICES, FINANCIALS, STRATEGY & DEVELOPMENT)*

  • 12.1. KEY COMPANIES
    • 12.1.1. THERMO FISHER SCIENTIFIC INC.
    • 12.1.2. MERCK KGAA
    • 12.1.3. GENSCRIPT BIOTECH CORPORATION
    • 12.1.4. AGILENT TECHNOLOGIES, INC.
    • 12.1.5. TAKARA BIO INC.
    • 12.1.6. PROMEGA CORPORATION
    • 12.1.7. BIO-RAD LABORATORIES, INC.
    • 12.1.8. QIAGEN N.V.
    • 12.1.9. LONZA GROUP LTD.
    • 12.1.10. NEW ENGLAND BIOLABS INC.
  • 12.2. KEY INNOVATORS
    • 12.2.1. SENGENICS
    • 12.2.2. PROTEOGENIX
    • 12.2.3. SYNTHETIC GENOMICS INC.

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

13. APPENDIX

  • 13.1. INDUSTRY INSIGHTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.5. AVAILABLE CUSTOMIZATIONS
  • 13.6. RELATED REPORTS
  • 13.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: PROTEIN EXPRESSION: MARKET SNAPSHOT
  • TABLE 2: PROTEINS SYNTHESIZED BY PROTEIN EXPRESSION AND GENETIC ENGINEERING
  • TABLE 3: PROJECTED INCREASE IN NUMBER OF CANCER PATIENTS, BY TYPE (2012 VS. 2015 VS. AND 2035)
  • TABLE 4: PHARMACEUTICAL PRODUCTS AND CELL LINES USED TO PRODUCE THEM
  • TABLE 5: GOVERNMENT FUNDING FOR PROTEIN-BASED RESEARCH (2013 - 2017)
  • TABLE 6: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2015-2022 (USD MILLION)
  • TABLE 7: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 9: E.COLI SYSTEMS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 10: OTHER PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 11: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 12: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 13: CHO SYSTEMS SEGMENT MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 14: OTHER MAMMALIAN CELL SYSTEMS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 15: INSECT CELL EXPRESSION SYSTEMS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 16: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 17: BACULOVIRUS SYSTEMS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: OTHER INSECT CELL SYSTEMS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 19: YEAST EXPRESSION SYSTEMS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 20: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 21: K. LACTIS SYSTEMS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 22: SACCHAROMYCES SYSTEMS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 23: PICHIA SYSTEMS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 24: OTHER YEAST SYSTEMS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 25: CELL-FREE EXPRESSION SYSTEMS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 26: ALGAL-BASED EXPRESSION SYSTEMS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 27: PROTEIN EXPRESSION MARKET, BY PRODUCT AND SERVICE, 2015-2022 (USD MILLION)
  • TABLE 28: PROTEIN EXPRESSION REAGENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 29: PROTEIN EXPRESSION VECTORS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 30: PROTEIN EXPRESSION COMPETENT CELLS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 31: PROTEIN EXPRESSION INSTRUMENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 32: PROTEIN EXPRESSION SERVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 33: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 34: THERAPEUTIC PROTEINS & THEIR APPLICATIONS
  • TABLE 35: THERAPEUTIC APPLICATIONS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 36: INDUSTRIAL APPLICATIONS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 37: RESEARCH APPLICATIONS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 38: PROTEIN EXPRESSION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 39: PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 40: ACADEMIC RESEARCH INSTITUTES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 41: CONTRACT RESEARCH ORGANIZATIONS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 42: OTHER END USERS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 43: PROTEIN EXPRESSION MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 44: NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 45: NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2015-2022 (USD MILLION)
  • TABLE 46: NORTH AMERICA: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 47: NORTH AMERICA: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 48: NORTH AMERICA: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 49: NORTH AMERICA: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 50: NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 51: NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 52: NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 53: U.S. BIOTECHNOLOGY MARKET, 2014-2015 (USD BILLION)
  • TABLE 54: U.S.: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2015-2022 (USD MILLION)
  • TABLE 55: U.S.: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 56: U.S.: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 57: U.S.: PROTEIN EXPRESSION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 58: CANADA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2015-2022 (USD MILLION)
  • TABLE 59: CANADA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 60: CANADA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 61: CANADA: PROTEIN EXPRESSION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 62: EUROPE: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 63: EUROPE: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2015-2022 (USD MILLION)
  • TABLE 64: EUROPE: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 65: EUROPE: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 66: EUROPE: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 67: EUROPE: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 68: EUROPE: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 69: EUROPE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 70: EUROPE: PROTEIN EXPRESSION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 71: GERMANY: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2015-2022 (USD MILLION)
  • TABLE 72: GERMANY: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 73: GERMANY: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 74: GERMANY: PROTEIN EXPRESSION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 75: FRANCE: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2015-2022 (USD MILLION)
  • TABLE 76: FRANCE: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 77: FRANCE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 78: FRANCE: PROTEIN EXPRESSION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 79: U.K.: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2015-2022 (USD MILLION)
  • TABLE 80: U.K.: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 81: U.K.: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 82: U.K.: PROTEIN EXPRESSION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 83: ITALY: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2015-2022 (USD MILLION)
  • TABLE 84: ITALY: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 85: ITALY: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 86: ITALY: PROTEIN EXPRESSION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 87: SPAIN: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2015-2022 (USD MILLION)
  • TABLE 88: SPAIN: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 89: SPAIN: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 90: SPAIN: PROTEIN EXPRESSION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 91: ROE: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2015-2022 (USD MILLION)
  • TABLE 92: ROE: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 93: ROE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 94: ROE: PROTEIN EXPRESSION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 95: ASIA: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 96: ASIA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2015-2022 (USD MILLION)
  • TABLE 97: ASIA: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 98: ASIA: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 99: ASIA: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 100: ASIA: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 101: ASIA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 102: ASIA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 103: ASIA: PROTEIN EXPRESSION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 104: CHINA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2015-2022 (USD MILLION)
  • TABLE 105: CHINA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 106: CHINA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 107: CHINA: PROTEIN EXPRESSION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 108: JAPAN: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2015-2022 (USD MILLION)
  • TABLE 109: JAPAN: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 110: JAPAN: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 111: JAPAN: PROTEIN EXPRESSION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 112: INDIA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2015-2022 (USD MILLION)
  • TABLE 113: INDIA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 114: INDIA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 115: INDIA: PROTEIN EXPRESSION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 116: ROA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2015-2022 (USD MILLION)
  • TABLE 117: ROA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 118: ROA: PROTEIN EXPRESSION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 119: ROA: PROTEIN EXPRESSION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 120: ROW: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2015-2022 (USD MILLION)
  • TABLE 121: ROW: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 122: ROW: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 123: ROW: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 124: ROW: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 125: ROW: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 126: ROW: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 127: ROW: PROTEIN EXPRESSION MARKET, BY END USER, 2015-2022 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 3: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 4: PROTEIN EXPRESSION MARKET: BOTTOM-UP APPROACH
  • FIGURE 5: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2017 VS. 2022 (USD BILLION)
  • FIGURE 8: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2017 VS. 2022 (USD BILLION)
  • FIGURE 9: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2017 VS. 2022 (USD BILLION)
  • FIGURE 10: PROTEIN EXPRESSION MARKET, BY END USER, 2017 VS. 2022 (USD BILLION)
  • FIGURE 11: PROTEIN EXPRESSION MARKET, BY REGION, 2017 VS. 2022 (USD BILLION)
  • FIGURE 12: GROWING PREVALENCE OF CHRONIC DISEASES IS DRIVING THE GROWTH OF THE PROTEIN EXPRESSION MARKET DURING THE FORECAST PERIOD
  • FIGURE 13: MAMMALIAN CELL EXPRESSION SYSTEMS WILL REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 14: ASIA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 15: PROTEIN EXPRESSION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 16: DIABETES CASES, 2015 VS. 2040 (MILLION)
  • FIGURE 17: PROKARYOTIC EXPRESSION SYSTEMS SEGMENT TO DOMINATE THE PROTEIN EXPRESSION MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: NORTH AMERICA TO DOMINATE THE PROKARYOTIC EXPRESSION SYSTEMS SEGMENT DURING 2017 AND 2022
  • FIGURE 19: REAGENTS SEGMENT TO DOMINATE THE PROTEIN EXPRESSION MARKET DURING THE FORECAST PERIOD
  • FIGURE 20: THERAPEUTIC APPLICATIONS TO DOMINATE THE PROTEIN EXPRESSION MARKET DURING THE FORECAST PERIOD
  • FIGURE 21: NORTH AMERICA TO DOMINATE THE THERAPEUTIC APPLICATIONS MARKET DURING THE FORECAST PERIOD
  • FIGURE 22: PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES SEGMENT TO DOMINATE THE PROTEIN EXPRESSION MARKET DURING THE FORECAST PERIOD
  • FIGURE 23: ASIA TO REGISTER THE HIGHEST GROWTH RATE IN THE GLOBAL PROTEIN EXPRESSION MARKET BETWEEN 2017 AND 2022
  • FIGURE 24: NORTH AMERICA: PROTEIN EXPRESSION MARKET SNAPSHOT
  • FIGURE 25: PROKARYOTIC EXPRESSION SYSTEMS TO ACCOUNT FOR THE LARGEST SHARE OF THE U.S. PROTEIN EXPRESSION MARKET IN 2017
  • FIGURE 26: EUROPE: PROTEIN EXPRESSION MARKET SNAPSHOT
  • FIGURE 27: ASIA: PROTEIN EXPRESSION MARKET SNAPSHOT
  • FIGURE 28: ROW: PROTEIN EXPRESSION MARKET SNAPSHOT
  • FIGURE 29: PROTEIN EXPRESSION MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2017
  • FIGURE 30: PROTEIN EXPRESSION MARKET: MARKET SHARE (2016)
  • FIGURE 31: THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 32: MERCK KGAA COMPANY SNAPSHOT (2016)
  • FIGURE 33: GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 34: AGILENT TECHNOLOGIES INC. (U.S.): COMPANY SNAPSHOT (2016)
  • FIGURE 35: TAKARA BIO INC. COMPANY SNAPSHOT (2016)
  • FIGURE 36: BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 37: QIAGEN N.V.: COMPANY SNAPSHOT (2016)
  • FIGURE 38: LONZA GROUP LTD.: COMPANY SNAPSHOT (2016)
Back to Top